Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 1 experimental medicine study of anti-CD3 monoclonal antibody in rheumatoid arthritis.

Immunotherapy advances·2025
Same author

Regulatory T cells and transplantation tolerance: Emerging from the darkness?

European journal of immunology·2021
Same author

Infectious tolerance. What are we missing?

Cellular immunology·2020
Same author

Coreceptor blockade targeting CD4 and CD8 allows acceptance of allogeneic human pluripotent stem cell grafts in humanized mice.

Biomaterials·2020
Same author

A Novel Role for Triglyceride Metabolism in Foxp3 Expression.

Frontiers in immunology·2019
Same author

Human Monoclonal Antibodies: The Benefits of Humanization.

Methods in molecular biology (Clifton, N.J.)·2018

Related Experiment Video

Updated: May 10, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Regulatory cells and transplantation tolerance.

Stephen P Cobbold1, Herman Waldmann

  • 1Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, United Kingdom. stephen.cobbold@path.ox.ac.uk

Cold Spring Harbor Perspectives in Medicine
|June 5, 2013
PubMed
Summary

Achieving transplantation tolerance requires understanding regulatory T cells (Tregs). These cells, expressing foxp3, are key to immune tolerance, but their mechanisms, including mTOR inhibition, are still being uncovered for human application.

More Related Videos

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

Related Experiment Videos

Last Updated: May 10, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity
08:41

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

Area of Science:

  • Immunology
  • Transplantation Biology
  • Cellular and Molecular Medicine

Background:

  • Transplantation tolerance remains a significant therapeutic challenge.
  • Regulatory T cells (Tregs), identified by foxp3 expression, are critical for achieving immune tolerance.
  • Current strategies for inducing tolerance are effective in mouse models but not yet in human clinical practice.

Purpose of the Study:

  • To elucidate the fundamental mechanisms governing the induction and function of donor antigen-specific Tregs.
  • To identify key molecular pathways, such as mTOR inhibition, involved in Treg-mediated tolerance.
  • To provide a foundation for developing targeted therapies to enhance Treg activity in transplantation.

Main Methods:

  • This study focuses on the mechanistic understanding of Treg induction and function.
  • It reviews current knowledge on molecular pathways utilized by Tregs.
  • Emerging critical components like mTOR inhibition are highlighted.

Main Results:

  • Regulatory T cells (Tregs) expressing the transcription factor foxp3 are essential for transplantation tolerance.
  • Donor-specific Tregs play a crucial role in maintaining immune tolerance post-transplantation.
  • The molecular mechanisms underlying Treg function are diverse and complex, with components like mTOR inhibition recently identified.

Conclusions:

  • A deeper understanding of Treg induction and function is necessary for translating transplantation tolerance to human clinical practice.
  • Targeting specific molecular mechanisms, including mTOR inhibition, holds promise for enhancing Treg-mediated tolerance.
  • Further research into Treg biology is crucial for advancing immunosuppressive therapies and improving transplant outcomes.